149 related articles for article (PubMed ID: 30221751)
1. Mycophenolate mofetil in paediatric autoimmune or immune-mediated diseases of the central nervous system: clinical experience and recommendations.
Nosadini M; Gadian J; Lim M; Sartori S; Thomas T; Dale RC
Dev Med Child Neurol; 2019 Apr; 61(4):458-468. PubMed ID: 30221751
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.
Nosadini M; Mohammad SS; Toldo I; Sartori S; Dale RC
Eur J Paediatr Neurol; 2019 Jan; 23(1):7-18. PubMed ID: 30318435
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.
Bitoun S; Bouvry D; Borie R; Mahevas M; Sacre K; Haroche J; Psimaras D; Pottier C; Mathian A; Hie M; Boutin DL; Papo T; Godeau B; Valeyre D; Nunes H; Amoura Z; Cohen Aubart F
Neurology; 2016 Dec; 87(24):2517-2521. PubMed ID: 27856779
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.
Chen H; Zhang Y; Shi Z; Feng H; Yao S; Xie J; Zhou H
Clin Neuropharmacol; 2016; 39(2):81-7. PubMed ID: 26818042
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome.
Al-Akash S; Al-Makdama A
Ann Saudi Med; 2005; 25(5):380-4. PubMed ID: 16270759
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
Koukoulaki M; Jayne DR
Nephron Clin Pract; 2006; 102(3-4):c100-7. PubMed ID: 16286784
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder.
Chen H; Qiu W; Zhang Q; Wang J; Shi Z; Liu J; Lian Z; Feng H; Miao X; Zhou H
Eur J Neurol; 2017 Jan; 24(1):219-226. PubMed ID: 27783452
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil monotherapy in the management of paediatric uveitis.
Chang PY; Giuliari GP; Shaikh M; Thakuria P; Makhoul D; Foster CS
Eye (Lond); 2011 Apr; 25(4):427-35. PubMed ID: 21423146
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
Androdias G; Maillet D; Marignier R; Pinède L; Confavreux C; Broussolle C; Vukusic S; Sève P
Neurology; 2011 Mar; 76(13):1168-72. PubMed ID: 21444902
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
Efe C; Taii HA; Ytting H; Aehling N; Bhanji RA; Hagström H; Purnak T; Muratori L; Werner M; Muratori P; Klintman D; Schiano TD; Montano-Loza AJ; Berg T; Larsen FS; Alkhouri N; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
Dig Dis Sci; 2018 May; 63(5):1348-1354. PubMed ID: 29569003
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study.
Xu Y; Wang Q; Ren HT; Qiao L; Zhang Y; Fei YY; Zhao Y; Cui LY
J Neurol Sci; 2016 Nov; 370():224-228. PubMed ID: 27772764
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation.
Evans HM; McKiernan PJ; Kelly DA
Transplantation; 2005 Jun; 79(11):1575-80. PubMed ID: 15940048
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis.
Santiago P; Schwartz I; Tamariz L; Levy C
Aliment Pharmacol Ther; 2019 Apr; 49(7):830-839. PubMed ID: 30761563
[TBL] [Abstract][Full Text] [Related]
15. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
West LD; Hart JR
J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil in the treatment of uveitis in children.
Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases.
Schneider-Gold C; Hartung HP; Gold R
Muscle Nerve; 2006 Sep; 34(3):284-91. PubMed ID: 16583368
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
Dehoux L; Hogan J; Dossier C; Fila M; Niel O; Maisin A; Macher MA; Kwon T; Baudouin V; Deschênes G
Pediatr Nephrol; 2016 Nov; 31(11):2095-101. PubMed ID: 27263020
[TBL] [Abstract][Full Text] [Related]
19. Differential efficacy of mycophenolate mofetil in adults with relapsing myelin oligodendrocyte glycoprotein antibody-associated disorders.
Wang M; Zeng P; Du C; Xue H; Cui Z; Zhang H; Jia D; Zhang C
Mult Scler Relat Disord; 2021 Aug; 53():103035. PubMed ID: 34077831
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder.
Huh SY; Kim SH; Hyun JW; Joung AR; Park MS; Kim BJ; Kim HJ
JAMA Neurol; 2014 Nov; 71(11):1372-8. PubMed ID: 25199960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
